Study guide
16.1 Controlled-Substance Storage and Security
Connecticut Multistate Pharmacy Jurisprudence Examination CT MPJE
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 About the Connecticut MPJE 1.2 Application, Fees, ATT, and Pearson VUE 1.3 Blueprint, Scoring, Retakes, and Study Strategy
2 Connecticut Regulatory Structure
2.1 DCP and the Commission of Pharmacy 2.2 Chapter 400j, 420b/420c, and RCSA 20-576 2.3 Federal vs Connecticut Law (More Restrictive Rule)
3 Pharmacist Licensure, Interns, PIC, and CE
3.1 Pharmacist Qualifications and Exam Path 3.2 Interns, Score Transfer, and Reciprocity 3.3 Pharmacist-in-Charge / Pharmacist Manager 3.4 License Renewal and Continuing Education
4 Technicians and Non-Pharmacist Personnel
4.1 Technician Registration and Certification 4.2 Community Technician Ratios (20-576-36) 4.3 Institutional Ratios and Advanced Pharmacy Technicians 4.4 Technician Limitations, Interns, and Unlicensed Staff
5 Discipline, Impairment, and Unlicensed Practice
5.1 Disciplinary Grounds (CGS § 20-579) 5.2 Impaired Practitioner Reporting and Programs 5.3 Unlicensed Practice, Penalties, and Appeals
6 Federal Drug Law Foundations
6.1 FDCA, Adulteration, and Misbranding 6.2 FDA Approval, Recalls, and OTC vs Rx 6.3 DSCSA, HIPAA, OBRA ’90, and PPPA
7 Federal Controlled Substances
7.1 CSA Schedules and Definitions 7.2 DEA Registration and Forms 222, 106, 41 7.3 Federal Controlled-Substance Prescription Rules 7.4 Inventory, Theft, Loss, and Disposal
8 Prescription Issuance in Connecticut
8.1 Who May Prescribe in Connecticut 8.2 Noncontrolled Prescription Form and Content 8.3 Controlled Prescriptions and the EPCS Mandate
9 Refills, Partial Fills, and Opioid Limits
9.1 Refill Authority (Noncontrolled and CIII–V) 9.2 Partial Fills of Schedule II Prescriptions 9.3 Connecticut Opioid Supply Limits (7-day / 5-day)
10 Administration, CDTM, and Standing Orders
10.1 Pharmacist Immunization Authority 10.2 Collaborative Drug Therapy Management 10.3 Naloxone and Opioid Antagonist Access 10.4 Emergency and Hormonal Contraception
11 Counseling, Confidentiality, and Returns
11.1 Counseling and Offer to Counsel 11.2 HIPAA and Connecticut Confidentiality 11.3 Return, Reuse, and Take-Back
12 Corresponding Responsibility and DUR
12.1 Corresponding Responsibility and Legitimate Medical Purpose 12.2 Prospective Drug Utilization Review 12.3 Exceptions and Conditions Prohibiting Dispensing
13 Transfers, Labeling, Packaging, and Delivery
13.1 Transferring Prescriptions 13.2 Labeling of Dispensed Drugs 13.3 Packaging and the Poison Prevention Packaging Act 13.4 Delivery of Drugs
14 CPMRS, Substitution, and Nonprescription Drugs
14.1 CPMRS Query and Reporting 14.2 Generic and Biosimilar Substitution 14.3 CMEA and Behind-the-Counter Products 14.4 OTC Labeling, Hazardous, and Restricted Nonprescription Drugs
15 Ordering, Records, and Inventories
15.1 Ordering and Acquisition (DEA 222/CSOS) 15.2 Distribution and DSCSA Records 15.3 Recordkeeping Content and Three-Year Retention 15.4 Controlled-Substance Inventories and CT Perpetual CII
16 Storage, Security, and Hazardous Drugs
16.1 Controlled-Substance Storage and Security 16.2 Hazardous Drugs (USP <800>, NIOSH) 16.3 Non-Pharmacist Access to Drugs
17 Compounding and Central Fill
17.1 Nonsterile Compounding (USP <795>, RCSA 20-576-69) 17.2 Sterile Compounding (USP <797>, RCSA 20-576-64) 17.3 Central Fill, 503A, and 503B Outsourcing
18 Pharmacy Permits and Practice Settings
18.1 Pharmacy License, Hours, Manager, and Signage 18.2 Nonresident, Hospital, Nuclear, and Automated Dispensing 18.3 Inspection, Closure, and Facility Discipline
16.1 Controlled-Substance Storage and Security
Key Takeaways Explain This Topic AI
RCSA § 21a-262-5 requires pharmacies newly licensed or relocating after January 1, 1975 to store all Schedule II stock in an approved safe (B burglary rating, relocking device, 750 pounds or securely anchored). A locked cash drawer is not an approved safe.
21 CFR 1301.75 lets pharmacies and institutional practitioners disperse Schedules II–V through noncontrolled stock. Connecticut is stricter: CII cannot be dispersed, and CIII–V dispersal is allowed only if RCSA § 21a-262-2(b) is met and no loss, theft, or diversion has occurred.
21 CFR 1301.71 requires effective controls and permits substantial compliance after an overall-security evaluation. 21 CFR 1301.72 is the manufacturer/distributor vault-and-safe rule, not the community-pharmacy default.
RCSA § 21a-262-2 keeps all schedules in a secure area accessible only to the minimum authorized staff, with cabinets and safes locked except for the time needed to remove or replace stock, and keys kept away from unauthorized persons.
Institutional pharmacies follow RCSA § 21a-262-8 quantity tiers for combined CII/III stock (locked cabinet under 150 units, approved safe 150–999, masonry room at 1,000 or more), and that stock is handled only by specifically authorized pharmacy personnel.
Last updated: August 2026
16.1 Controlled-Substance Storage and Security
Quick Answer: DEA 21 CFR 1301.71 demands effective controls against theft and diversion and will accept substantial compliance with §§ 1301.72–1301.76 . Pharmacies are practitioners under 21 CFR 1301.75 : a securely locked, substantially constructed cabinet , or (federally) dispersal of CII–V through noncontrolled stock. Connecticut is stricter. RCSA § 21a-262-5 puts community Schedule II in a completely enclosed locked wood or metal cabinet (< 150 controlled-substance units) or an approved safe (≥ 150 units). Pharmacies newly licensed or relocating after January 1, 1975 store all CII in an approved safe . Do not put oxycodone in a flimsy cash drawer . 21 CFR 1301.72 is the manufacturer/distributor vault rule, not the retail default.
NABP Competency 4.2.2 is non-hazardous (including controlled) storage. The scored miss is mixing who the federal section applies to, then forgetting that Connecticut’s 21a-262 series is the more-restrictive overlay Chapter 2 already taught.
Federal floor — substantial compliance, then the right section
21 CFR 1301.71(a) requires every applicant and registrant to provide effective controls and procedures to guard against theft and diversion . DEA uses §§ 1301.72–1301.76 as the measuring stick. 1301.71(b) is the phrase the exam quotes: substantial compliance with those standards may be deemed sufficient after DEA evaluates the overall security system . Location, quantity, building construction, key control, alarms, unsupervised public access, visitor handling, and local police response are all on that list. A locked box that fails the overall picture still fails 1301.71 .
Know which numbered section belongs to which business:
21 CFR 1301.72 — physical security for non-practitioners (manufacturers, distributors, importers, exporters) and narcotic-treatment programs. Schedule I/II go in a specified safe or steel cabinet (or a vault ). A safe under 750 pounds is bolted or cemented . Alarms, if required by quantity and type, signal a central station, police, or a 24-hour registrant control station. This is not the community-pharmacy paragraph.
21 CFR 1301.75 — physical security for practitioners , including pharmacies . Schedule I in a securely locked, substantially constructed cabinet. Schedules II, III, IV, and V in the same kind of cabinet — however, pharmacies and institutional practitioners may disperse those substances throughout noncontrolled stock in a manner that obstructs theft or diversion . Thiafentanil, carfentanil, etorphine hydrochloride, and diprenorphine go in a Class V equivalent safe; they are not ordinary community bottles.
21 CFR 1301.76(a) — do not employ, as an agent with access to controlled substances , a person convicted of a felony relating to controlled substances , or a person who had a DEA registration denied, revoked, or surrendered for cause .
A Hartford PIC who cites 1301.72 as the reason the store must pour an 8-inch concrete vault has grabbed the wholesaler rule. A PIC who cites 1301.75 dispersal as permission to leave oxycodone on an open fast-mover shelf has ignored Connecticut .
Connecticut’s 21a-262 series — units, safes, and the 1975 line
CGS § 21a-262 authorizes the Commissioner of Consumer Protection to set minimum security and safeguard standards for storage and handling. The operative pharmacy text is RCSA §§ 21a-262-1 through 21a-262-10 .
RCSA § 21a-262-1(b): if state and federal schedules conflict, treat the drug as being in the schedule that provides the highest degree of control . § 21a-262-1(e) defines a controlled-substance unit for security math:
- 100 tablets or capsules = 1 unit
- One pint of liquid = 1 unit
- ½ ounce of powder, crystal, flake, or granule = 1 unit
- One multiple-dose vial = 1 unit
- Ten suppositories = 1 unit
- Ten single-dose ampules, Tubexes, or similar = 1 unit
Total the units currently on hand . Partial containers count as full. A 50-count bottle is 0.5 unit . That arithmetic, not a gut feeling about “a lot of oxycodone,” is what trips the cabinet-versus-safe thresholds.
An approved safe ( § 21a-262-1(f) ) means a pre-1975 approved safe or a safe that meets all of: (1) minimum B burglary rating ; (2) a relocking device ; (3) 750 pounds or more , or securely anchored to a permanent structure; and (4) adequate interior space for every controlled substance required to be inside it. A fireproof file cabinet, a lockable cash drawer, and a plastic lockbox bolted to a pegboard do not match that list.
Licensed pharmacies — RCSA § 21a-262-5
Stock Connecticut storage Federal 1301.75 overlay
Schedule II, < 150 units Substantially constructed, completely enclosed, locked wood or metal cabinet Cabinet or (federally) dispersal; CT forbids CII dispersal
Schedule II, ≥ 150 units Approved safe Same
Any CII in a pharmacy newly licensed or relocating after January 1, 1975 Approved safe for all CII , regardless of unit count Same
Schedules III, IV, V Approved safe, locked metal or wood cabinet, or dispersed through stock in the prescription compounding area Dispersal allowed federally
CIII–V dispersal extra conditions § 21a-262-2(b) minimum-access rule and no loss, theft, or diversion of any schedule has occurred Federal dispersal has no “prior theft” shutoff
The January 1, 1975 sentence is the 2026 community default. A pharmacy licensed last year, a relocation down the block, and almost every chain remodel put all CII in an approved safe . The <150-unit cabinet path is a grandfather rule, not a loophole for a new Stamford store.
§ 21a-262-5(c)–(d): after loss, theft, burglary, or diversion of any schedule, the Commissioner determines storage and security for all controlled substances in that pharmacy and shall require additional safeguards . The Commissioner may also require an approved safe or locked cabinet whenever overall conditions warrant it. RCSA § 21a-262-2(f) gives a clock: extra safeguards (vault, safe, locked cage or room, substantially constructed cabinet, or electrical protection) within 90 days of the occurrence; hospitals get 180 days .
§ 21a-262-2 applies in all instances :
All schedules sit in a secure area accessible only to specifically authorized personnel , and authorization goes to the minimum number of employees absolutely essential for efficient operation.
Vaults, safes, cages, cabinets, and enclosures stay securely locked except for the actual time required to remove or replace needed items . Locks stay in working order with keys removed . Keys are not left where unauthorized people can take them.
Do not keep stock in excess of the quantity actually required for normal, efficient operation.
Stock stored out of compliance , or at a location other than the DEA-registered address , is subject to seizure .
Alarms are not a universal community-pharmacy mandate in 21a-262-5, but § 21a-262-2(a) lets the Commissioner require electrical alarm protection and hold-up buttons where special hazards exist (large stock, exposed handling, unusual vulnerability). After-hours prescription-department alarms are a different regulation ( RCSA § 20-576-18 , section 16.3).
Institutional versus retail
RCSA § 21a-262-8 covers hospital drug rooms, satellite pharmacies, hospital clinical laboratories, and similar institutional pharmacies. Combined Schedule II and III stock:
Fewer than 150 units — separate, secure, substantially constructed locked metal or wood cabinet (hospital clinical laboratories store CII in an approved safe even at small quantities).
150 to fewer than 1,000 units — approved safe .
1,000 units or more — completely enclosed masonry room (or equivalent) with a vault-type steel door, combination lock, and relocking device; a day gate if the room stays open for frequent access; electrical alarm if constructed after January 1, 1975 .
CIV and CV in that pharmacy sit in a secure location within the prescription compounding area or drug room (clinical labs: separate locked location). § 21a-262-8(c) is the access sentence: controlled-substance stock shall not be accessible to other than specifically authorized pharmacy personnel , and shall be handled by authorized pharmacy personnel only . Floor nurses do not wander the hospital CII vault; nursing-station and emergency-kit rules live in § 21a-262-9 (double-locked, nonportable CII cabinet, two different keys, shift-to-shift signed inventory).
Practitioners’ offices ( § 21a-262-6 ) are a third pattern: CII/III totaling 15 units or less in a locked substantially constructed cabinet; more than 15 units in an approved safe . Do not import the office-15-unit number into a community pharmacy stem.
Realistic Connecticut scenario
A New Haven independent licensed in 2019 keeps oxycodone 15 mg in a lockable cash drawer under the counseling window “because 21 CFR 1301.75 only says substantially constructed cabinet, and the drawer locks.” That drawer is not an approved safe , and § 21a-262-5 required an approved safe the day the pharmacy was licensed after 1975 . Moving the same bottles onto the regular fast-mover shelf “to disperse them like DEA allows” still fails Connecticut: CII is not the dispersal schedule under § 21a-262-5 . Alprazolam (CIV) may be dispersed only if no controlled-substance loss has already occurred at that pharmacy; after last quarter’s missing #100 oxycodone, even CIV dispersal is closed until the Commissioner’s additional safeguards are in place. Citing 1301.72 and pouring a distributor vault does not fix the cash-drawer problem, and leaving the safe key on a hook by the time clock violates § 21a-262-2(c) .
CT may be stricter; more-restrictive wins.
Official anchors
RCSA § 21a-262-5 — licensed-pharmacy CII cabinet/safe; 1975 approved-safe rule; CIII–V dispersal limits.
RCSA § 21a-262-1 — units; approved safe; schedule-conflict rule.
RCSA § 21a-262-2 — minimum access, locked storage, keys, post-loss upgrades.
RCSA § 21a-262-8 — institutional quantity tiers and authorized-personnel-only handling.
21 CFR 1301.71 , 1301.72 , 1301.75 , 1301.76 — substantial compliance; non-practitioner vaults; practitioner cabinets and dispersal; employee screening.